Cargando…
Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets
OBJECTIVE: The off-target effects and severe side effects of PPARα and LXRα agonists greatly limit their application in atherosclerosis (AS). Therefore, this study intended to use mesoporous silica nanoparticles as carriers to generate MnO nanoparticles in situ with T1WI-MRI in mesoporous pores and...
Autores principales: | Zhang, Wei, Lv, Zheng, Zhang, Yupeng, Gopinath, Subash C. B., Yuan, Yi, Huang, Deyou, Miao, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537012/ https://www.ncbi.nlm.nih.gov/pubmed/36211824 http://dx.doi.org/10.1155/2022/6006601 |
Ejemplares similares
-
PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells
por: Li, Tianjiao, et al.
Publicado: (2019) -
Iodine-125-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent
por: Su, Ning, et al.
Publicado: (2015) -
Endothelial Cell Targeting by cRGD-Functionalized Polymeric Nanoparticles under Static and Flow Conditions
por: Martínez-Jothar, Lucía, et al.
Publicado: (2020) -
Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic Payload
por: Perrins, Richard D., et al.
Publicado: (2022) -
Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015)